• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Funds

Apposite Capital closes Healthcare Fund II on £144.5m

  • Greg Gille
  • Greg Gille
  • @unquotenews
  • 12 June 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

UK-based small-cap investor Apposite Capital has raised £144.5m for its Apposite Healthcare Fund II vehicle.

According to Unquote Data, the fund was launched in 2015 and went on to hold a first close on £70m in 2016. The fundraising effort eventually surpassed the £125m target.

Its predecessor raised £200m shortly after the firm's inception in 2006 and has now been fully realised.

Apposite Healthcare Fund II

  • Target:

    £125m

  • Launched:

    2015

  • Closed on:

    £144.5m, Jun 2018

  • Focus:

    UK healthcare, buyout & growth capital

  • Fund manager:

    Apposite Capital

Fundraising efforts for the second vehicle have been led in-house with the support of TMR Strategic as lead placement agent. Macfarlanes acted as legal adviser, while Intertrust is the fund administrator.

In conjunction with the fundraise, Valerie Auffray has been promoted to head of investor relations & operations and Anne-Laure Meynier to investment director. Auffray joined Apposite in 2008 and is responsible for fundraising, investor relations, funds reporting and marketing, as well as the firm's operations. Meynier joined the firm in 2015 and is involved in all aspects of the investment process.

Investors
Apposite stated that it had received "strong support" from existing investors. According to Unquote Data, LPs in the previous vehicle include Mizuho Bank and Dainippon Sumitomo Pharma.

In addition, Apposite said it had attracted a varied mix of new investors comprising funds-of-funds, financial institutions, family offices, endowments, foundations and corporates. LPs hail from Europe, Asia and the US.

Investments
Apposite focuses exclusively on the healthcare sector, seeking to deploy £10-20m over the life of an investment. It favours majority investments but can also deploy growth capital.

The fund has already been put to work across five investments. Most recently, Apposite acquired OrthoD, a UK-based manufacturer and distributor of medical products and implants, from The Riverside Company earlier this year. Other deals are Medical Imaging Partnership, MC Care Holdings, NIMGenetics and Swanton Care & Community.

People
Apposite Capital – David Porter (managing partner); Valerie Auffray (head of investor relations & operations).

head of investor relations & operations

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Funds
  • Buyout
  • UK / Ireland
  • Healthcare
  • Apposite Capital
  • United Kingdom

More on Funds

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
Andris K. Berzins of Change Ventures
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • Funds
  • 31 August 2023
Fund launches in euros
Iron Wolf Capital targets EUR 70m for second vehicle

Baltic investor anticipates early 2024 launch and will focus on early-stage AI and deeptech startups

  • Funds
  • 30 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013